Catalase and α-enolase: Two novel granulocyte autoantigens in inflammatory bowel disease (IBD)

Clinical and Experimental Immunology

Volumn 112, Issue 1, 1998, Pages 10-16

  Roozendaal, C ^a   Zhao, M H ^c   Horst, G ^a   Lockwood, C M ^c   Kleibeuker, J H ^a   Limburg, P C ^a   Nelis, G F ^b   Kallenberg, C G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Sophia Hospital   (Netherlands)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

enolase; Anti neutrophil; Catalase; Cytoplasmic antibodies; Inflammatory bowel disease

Indexed keywords

AUTOANTIGEN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATALASE; ENOLASE; LACTOFERRIN; LEUKOCYTE ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; ULCERATIVE COLITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIGENS; CATALASE; GRANULOCYTES; HUMANS; INFLAMMATORY BOWEL DISEASES; PHOSPHOPYRUVATE HYDRATASE;

EID: 0031972187     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00528.x     Document Type: Article

References (43)

1. Van der Woude FJ, Lobatto S, Permin H et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomalosis. Lancet 1985; i:425-9.
2. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysioogical potential. Kidney Int 1994; 46:1-15.
3. Kallenberg CGM, Brouwer E, Mulder AHL et al. ANCA - pathophysiology revisited. Clin Exp Immunol 1995; 100:1-3.
4. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93:675-82.
5. Peen E, Almer S, Bodemar G et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993; 34:56-62.
6. Mulder AHL, Broekroelofs J, Horst G et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994; 95:490-7.
7. Stoffel MP, Csernok E, Herzberg C et al. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996; 104:54-59.
8. Walmsley RS, Zhao MH, Hamilton ML et al. Anti-neutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997; 40:105-9.
9. Mayet WJ, Hermann E, Finsterwalder J et al. Antibodies to cathepsin G in Crohn's disease. Eur J Clin Invest 1992; 22:427-33.
10. Lesavre P, Nusbaum P, Halbwachs-Mecarelli L. Methods of detection of anticathepsin G autoantibodies in human. Adv Exp Med Biol 1993; 336:257-61.
11. Sobajima J, Ozaki S, Okazaki T et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996; 105:120-4.
12. Kossa K, Coulthart A, Ives CT et al. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:783-9.
13. Schmitt WH, Csernok E, Flesch BK et al. Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA). Adv Exp Med Biol 1993; 336:267-72.
14. Nassberger L, Ljungh A, Schumacher G, Kollberg B. β-Glucoronidase antibodies in ulcerative colitis. Lancet 1992; 340:734-5.
15. Sobajima J, Ozaki S, Osakada F et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins. HMG1 and HMG2. Clin Exp Immunol 1997; 107:135-40.
16. O'Morain C, Tobin A, Leen E et al. Criteria of case definition in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1989; 24:7-11.
17. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (Suppl. 6):12-13.
18. Van der Giessen M, Huitema MG, Cohen Tervaert JW, Kallenberg CGM. A technical note on the routinely performed ANCA detection. APMIS 1989; 97 (Suppl. 6):37.
19. Mulder AHL, Horst G, Haagsma EB et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatol 1993; 17:411-7.
20. Monajemi H, Meenan J, Lamping R et al. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterol 1996; 110:733-9.
21. Dentener MA, Francot GJM, Smit FT et al. Presence of bactericidal/ permeability-increasing protein in disease: detection by ELISA. J Infect Dis 1995; 171:739-43.
22. Olofsson T, Olsson I. Purification of human granulocyte catalase in chronic myeloid leukemia. Biochim Biophys Acta 1977; 482:301-8.
23. Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227:407-15.
24. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99:49-56.
25. Matsudaira P. Sequence from picomole quantities of proteins electro-blotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262:10035-8.
26. Hewick RM, Hunkapiller MW, Hood LE, Dreyer WJ. A gas-liquid solid phase peptide and protein sequenator. J Biol Chem 1981; 356:7990-7.
27. Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis. Anal Biochem 1992; 203:173-9.
28. Quan F, Korneluk RG, Tropak MB, Gravel RA. Isolation and characterization of the human catalase gene. Nucl Acids Res 1986; 14:5321-35.
29. Giallongo A, Feo A, Moore R et al. Molecular cloning and nucleotide sequence of a full-length cDNA for human a enolase. Proc Natl Acad Sci USA 1986; 83:6741-5.
30. Shanahan F. Neutrophil autoantibodies in inflammatory bowel disease: are they important? Gastroenterol 1994; 107:586-9.
31. Kaneko K, Suzuki Y, Yamashiro Y, Yabuta K. Is p-ANCA in ulcerative colitis directed against β-glucuronidase? Lancet 1993; 341:320.
32. Mulder AHL, Horst G, Van Leeuwen MA et al. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlates. Arthritis Rheum 1993; 36:1054-60.
33. Moodie FDL, Leaker B, Cambridge G et al. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int 1993; 43:675-81.
34. Deisseroth A, Dounce AL. Catalase: physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970; 50:319-75.
35. Schonbaum GR, Chance B. Catalase. In: Boyer P, ed. The enzymes, Vol. XIII, 3rd edn. New York: Academic Press, 1976:363-408.
36. Ballinger CA, Mendis-Handagama SMLC, Kalmar JR. et al. Changes in the localization of catalasse during differentiation of neutrophilic granulocytes. Blood 1994; 83:2654-68.
37. Wold F, Enolase. In: Boyer P, ed. The enzymes, Vol. V, 3rd edn. New York: Academic Press, 1971:499-537.
38. Falk RJ, Terrell RS, Charles LA, Jennette C. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
39. Mulder AHL, Heeringa P, Brouwer E et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies: a FcγRII-dependent process. Clin Exp Immunol 1994; 98:270-8.
40. Mulder AHL, Stegeman CA, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995; 101:227-32.
41. Van de Wiel BA, Dolman KM, Van der Meer-Gerritsen CH et al. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992; 90:409-14.
42. Griffin SV, Lockwood CM. Anti-myeloperoxidase (MPO) antibodies interfere with the inhibition of MPO by caeruloplasmin. The Immunologist 1997; 5 (Suppl. 1):94 (Abstr.).
43. Heeringa P, Brouwer E, Cohen Tervaert JW et al. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int, in press.